Settings
Light Theme
Dark Theme
Podcast Cover

Capirci di più non è difficile

  • Solari parte 2: sicurezza

    8 JUN 2020 · FDA: "The public record does not contain sufficient data to support a positive GRASE (generally recognized as safe and effective) determination for cinoxate, dioxybenzone, ensulizole, homosalate, meradimate, octinoxate, octisalate, octocrylene, padimate O, sulisobenzone, oxybenzone , avobenzone at this time" Nomi diversi degli stessi principi: Homosalate = Acido benzoico, 2-idrossi-, 3,3,5-trimetilcicloesil estere Ossibenzone / Oxybenzone = Benzophenone-3 ; 2-idrossi-4metossibenzofenone Ensulizole = Phenylbenzidamizole Sulfonic Acid ; Acido 2-fenil-benzimidazolo5 solfonico Avobenzone = Benzylidene Camphor Sulfonic Acid ; Acido alfa (ossi-2-bornilidene-3-)-toluene-4- solfonico Octocrylene = Acido 2-ciano-3,3-difenilacrilico, estere 2 etilesile Octinossato / Octinoxate = Ethylhexyl Methoxycinnamate ; 4-metossicinnamato di 2-etilesile Octisalato = 2-etilesil salicitato ; Ethylhexyl Salicylate Sulisobenzone = Benzophenone-4, Benzophen one-5 ; Acido-2-idrossi-4-metossibenzofenone-5-sulfonico [benzofenone-5] BIBLIOGRAFIA https://www.federalregister.gov/documents/2019/02/26/2019-03019/sunscreen-drug-products-for-over-the-counter-human-use https://eur-lex.europa.eu/legal-content/IT/TXT/PDF/?uri=CELEX:02009R1223-20191218&from=EN https://www.govinfo.gov/content/pkg/FR-2019-02-26/pdf/2019-03019.pdf https://jamanetwork.com/journals/jama/article-abstract/2759002 https://www.flsenate.gov/Session/Bill/2020/113/Analyses/h0113f.HHS.PDF https://www.fda.gov/news-events/fda-brief/fda-brief-fda-announces-results-second-sunscreen-absorption-study http://customsandinternationaltradelaw.com/2019/09/10/major-changes-fda-proposing-make-sunscreen-rule/ https://www.ilmessaggero.it/salute/prevenzione/protezione_solare_pelle_creme-4335384.html https://www.engage.hoganlovells.com/knowledgeservices/viewContent.action?key=Ec8teaJ9Vaq2cul5mTGKwq%2FdwZ0I6NkpBiaRvcQ1%2B0trYQ6QELAnKE%2BuQ3%2BHDx%2Bw2KrC1KhpPe4%3D&nav=FRbANEucS95NMLRN47z%2BeeOgEFCt8EGQLgG0HP2%2Bl9M%3D&pdfview=true
    11m 3s
  • Solari parte 1: efficacia

    1 JUN 2020 · BIBLIO SOLARI https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736991/#B53 https://www.ewg.org/sunscreen/report/imperfect-protection/ https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02009R1223-20190813 https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02009R1223-20190813 https://eur-lex.europa.eu/legal-content/IT/TXT/HTML/?uri=CELEX:32006H0647&from=EN
    14m 58s
  • Farmaci e vaccini Covid in Europa

    23 MAY 2020 · BIBLIO COVID EU https://www.ecdc.europa.eu/en/about-ecdc https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines-covid-19 https://www.ema.europa.eu/en/implications-coronavirus-disease-covid-19-methodological-aspects-ongoing-clinical-trials#current-version-section https://www.ema.europa.eu/en/documents/other/summary-compassionate-use-remdesivir-gilead_en.pdf https://www.ema.europa.eu/en/implications-coronavirus-disease-covid-19-methodological-aspects-ongoing-clinical-trials#current-version-section https://www.ema.europa.eu/en/documents/other/conditions-use-conditions-distribution-patients-targeted-conditions-safety-monitoring-adressed_en-2.pdf https://www.ema.europa.eu/en/documents/press-release/international-coordination-needed-encourage-conduct-large-decision-relevant-covid-19-clinical-trials_en.pdf https://www.ema.europa.eu/en/human-regulatory/research-development/compassionate-use https://www.aifa.gov.it/sperimentazioni-cliniche-covid-19
    14m 46s
  • Vaccino morbillo

    17 MAY 2020
    11m 51s
  • Vaccino Pertosse

    12 MAY 2020 · biblio pertosse https://www.ecdc.europa.eu/en/annual-epidemiological-reports https://www.sigo.it/wp-content/uploads/2019/03/Vaccinazioni_in_Gravidanza_14-03-19.pdf https://www.ncbi.nlm.nih.gov/pubmed/31991855 https://www.ncbi.nlm.nih.gov/pubmed/29482390 https://www.ncbi.nlm.nih.gov/pubmed/26542059 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/813292/hpr2219_prtsss.pdf https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158661/#B64-vaccines-08-00046
    9m 40s
  • 3m 5s
  • 15m

Sono farmacologa, ho sempre lavorato nella ricerca e sperimdelle fonti che utilizzoentazione sui farmaci: nell’Industria Farmaceutica, nell'Agenzia Regolatoria, in Università, e in due Comitati Etici. Ho lavorato per l’Agenzia Europea...

show more
Sono farmacologa, ho sempre lavorato nella ricerca e sperimdelle fonti che utilizzoentazione sui farmaci: nell’Industria Farmaceutica, nell'Agenzia Regolatoria, in Università, e in due Comitati Etici.
Ho lavorato per l’Agenzia Europea EMA, per l’Autorità Francese HAS e per l’Agenzia italiana AIFA.

Parlo di terapie, di medicinali, di prevenzione. Intendo frequentare quello spazio di conoscenza che sta tra gli articoli scientifici e la normativa internazionale da un lato, e la stampa "laica” dall'altro, garantendo assolutamente il rigore e l'affidabilità delle fonti che utilizzo, che citerò sempre. Intendo dimostrare che “capirci di più” è possibile, assolutamente, e anche molto interessante.
I miei podcast non hanno e non avranno mai alcuna finalità commerciale.
show less
Information
Author simonetta paola raimondo
Categories Medicine
Website -
Email -

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search